Evaluation of novel immunocytokines that preferentially target high or intermediate affinity IL-2 receptors
Citation
Journal for ImmunoTherapy of Cancer. 2014 Nov 06;2(Suppl 3):P118
Rights
Zulmarie Perez Horta et al.; licensee BioMed Central Ltd.